Fesarius Therapeutics demonstrates the science that establishes DermiSphere™ hDRT in a class of its own

NEW YORK, April 30, 2026 /PRNewswire/ -- FesariusTherapeutics, Inc., a commercial stage bioregenerative technology company focused on the development, manufacture and commercialization of solutions for the Advanced Reconstructive Surgery and Regenerative Medicine markets, is pleased to...